Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine. Chin J Integr Med 2013;19:86–91.Zou C,Lu ZY,Wu YC,et al.Colon may provide new therapeutic targets for treatment of chronic kidney disease with chinese medicine[J].Chinese J Integra Med,...
Autophagy, the intracellular lysosomal degradation process plays a pivotal role in podocyte homeostasis in diabetic kidney disease (DKD). Lysosomal function, autophagic activity, and their actions were investigated in vitro and in vivo. We found that LC3
“We are pleased to announce that a new completely domestic drug Sevella for the treatment of chronic kidney disease has become available to Russia’s residents. Uninterrupted provision of patients with highly effective drugs is one of PSK Pharma’s key values, which is why ...
There are vulnerable populations in many parts of the globe with access to low resources, among which racial and ethnic minorities and indigenous peoples, in which detection campaigns have shown a high burden of kidney disease that usually remains hidden, without treatment and free to deteriorate. ...
Despite nearly two million people dying of acute kidney injury every year, and tens of millions more needing treatment, no effective drug treatment for the condition is available. Furthermore, most acute kidney injury patients are elderly with poor progn
Key words Chronic kidney disease;Diabetic nephropathy;Dialysis; Nutritional status 前言 慢性肾脏病(Chronic Kidney Disease,CKD)是指在几个月内或者若干年期间内肾功能渐渐发生类似难以逆转的衰退。由于患病周期长,并且消耗大量医疗卫生资源,慢性肾脏病是一种严重威胁人类健康的常见慢性代谢性病 [1] 。我国几大城市...
“Adult stem cells have proved promising for the treatment of a wide range of diseases, including kidney disease,” she said. “We decided to investigate how adult stem cells could help reduce the scarring effect. We demonstrated that adult stem cells and serelaxin on their own have a limited...
Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review Author links open overlay panelMaria Erika G. Ramirez, Joanne M. BargmanShow more Add to Mendeley Share Cite https://doi.org/10.1016/j.jare.2017.04.006Get rights and content Under a...
Improvements in our understanding of the pathogenesis of fibrosis associated with diabetic kidney disease have led to the identification of several novel targets for the treatment of diabetic nephropathy. Albuminuria is a useful clinical marker of diabetic nephropathy, as it can be used to predict a ...
The traditional strategies for prevention and treatment of DKD, i.e., glycemic control and blood pressure management, have only modest effects on minimizing glomerular filtration rate decline or progression to end-stage kidney disease. While cardiovascular outcome trials of SGLT-2i show a positive ...